{"url":"https://lda.senate.gov/api/v1/filings/2d55bd7b-756f-4efd-bc05-1b4a1edabc0c/","filing_uuid":"2d55bd7b-756f-4efd-bc05-1b4a1edabc0c","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2d55bd7b-756f-4efd-bc05-1b4a1edabc0c/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Lawrence C Grossman","dt_posted":"2022-02-17T12:36:53-05:00","termination_date":"2021-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 New York Ave., NW Suite 925","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":87814,"url":"https://lda.senate.gov/api/v1/registrants/87814/","house_registrant_id":36633,"name":"CT GROUP FKA CTF GLOBAL LLC","description":"consultant in government relations","address_1":"1401 New York Ave., NW Suite 925","address_2":"Suite 250","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LAWRENCE C. GROSSMAN","contact_telephone":"+1 202-413-1215","dt_updated":"2026-02-12T06:21:06.902001-05:00"},"client":{"id":204709,"url":"https://lda.senate.gov/api/v1/clients/204709/","client_id":850,"name":"PARATEK","general_description":"Developer and manufacturer of antibiotics and infectious disease drugs","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"issues impacting domestic antibiotic development and preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68373,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":"K.","last_name":"BRADISH","suffix":null,"suffix_display":null},"covered_position":"Legis. Dir., Office of Sen. Arlen Specter","new":false},{"lobbyist":{"id":68374,"prefix":null,"prefix_display":null,"first_name":"LAWRENCE","nickname":null,"middle_name":"C.","last_name":"GROSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}